afo-18
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT01141205)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- afo-18
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01009762 | Phase 1 | Sep 1, 2009 | Government of Denmark, Statens Serum Institut, University of Copenhagen |
| NCT01141205 | Phase 1 | Aug 1, 2009 | Bandim Health Project, European and Developing Countries Clinical Trials Partnership (EDCTP), Government of Denmark, Statens Serum Institut |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Denmark | Government | 2 | 0 | 1 | 2009 |
| Statens Serum Institut | Academic/Hospital | 2 | 1 | 1 | 2009 |
| Bandim Health Project | Government | 1 | 0 | 1 | 2009 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2009 |
5 organizations
Page 1 / 1